Last reviewed · How we verify

Ovitrelle — Competitive Intelligence Brief

Ovitrelle (Ovitrelle) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

marketed Lutropin-choriogonadotropic hormone receptor Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Ovitrelle (Ovitrelle) — Hadassah Medical Organization.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ovitrelle TARGET Ovitrelle Hadassah Medical Organization marketed Lutropin-choriogonadotropic hormone receptor
Luveris r-hLH Merck KGaA marketed Gonadotropin Lutropin-choriogonadotropic hormone receptor 2004-01-01
Ovidrel CHORIOGONADOTROPIN ALFA Merck KGaA marketed Gonadotropin Lutropin-choriogonadotropic hormone receptor 2000-01-01
Zoladex Zoladex University of Michigan Rogel Cancer Center marketed Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor
Cetrotide Cetrotide Wolfson Medical Center marketed Gonadotropin-releasing hormone receptor, Lutropin-choriogonadotropic hormone receptor
Ovidrel Ovidrel Nanjing University marketed Lutropin-choriogonadotropic hormone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ovitrelle — Competitive Intelligence Brief. https://druglandscape.com/ci/ovitrelle. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: